戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  disease events (relative risk with abnormal exercise tolerance testing, 2.0 to 5.0).
2 cumented coronary artery disease, a positive exercise tolerance test, and stable chronic angina pecto
3 nsional echocardiography, Holter monitoring, exercise tolerance testing, and ajmaline provocation.
4 , CA, and Washington DC, USA, who had had an exercise tolerance test between 1986, and 2011.
5 principally in middle-aged men, suggest that exercise tolerance testing can provide independent progn
6                           Although screening exercise tolerance testing detects severe coronary arter
7 a and enhances functional capacity during an exercise tolerance test (ETT) in patients with coronary
8 on or myocardial infarction (MI), with a pre-exercise tolerance test (ETT) likelihood of CAD > or =0.
9 postinfarction angina or a strongly positive exercise tolerance test (ETT) typically had cost-effecti
10 , exercise, and nuclear models by use of pre-exercise tolerance test (ETT), post-ETT, and nuclear inf
11  depression > or =1 mm from baseline) during exercise tolerance testing (ETT) was examined in patient
12                                              Exercise tolerance testing has been proposed as a means
13 le cohort studies demonstrate that screening exercise tolerance testing identifies a small proportion
14 Efficacy was evaluated at 90 and 180 days by exercise tolerance test, myocardial nuclear perfusion im
15 dical treatment and, if stable, predischarge exercise tolerance testing (n = 1106).
16                         Deterioration in all exercise tolerance test parameters occurred in patients
17  to limiting angina during bicycle exercise (exercise tolerance tests), performed at trough of drug a
18 s were similar in the 2 approaches, with the exercise tolerance test result exerting the greatest lev
19 ta-blocker therapy underwent cardiopulmonary exercise tolerance testing under 2 conditions in random

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。